Obesity

Is obesity a disease or a risk factor for disease? It's a contentious question. In a new report, the Global Commission on Clinical Obesity strives to settle the enduring debate, introducing a new framework that seeks to redefine obesity.

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs; that number falls significantly when they learn the weight might come back when the meds are stopped. It’s something that has medical professionals concerned.

Balloons that trick the stomach into feeling full have long been used for weight loss. But, they become less effective the longer they stay inflated. Engineers have devised a balloon that inflates and deflates on demand – it reduced food intake by 60%.

A new study has found a link between the rollout of high-speed internet services and a rise in obesity rates. The researchers who conducted the study attribute the increase to the effect of high-speed internet access on physical activity and eating habits.

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve physical functioning following weight loss, according to the results of a recent clinical trial by Novo Nordisk, the drug’s manufacturer.

The race is on to deliver the first once-a-day weight-loss pill that would be both cheaper and less invasive than the current injectable drugs, with strong results from Terns following those from competitors Eli Lilly, Pfizer, Roche and Structure.

While being a night owl has a certain cachet, a new study shows that staying up into the wee hours can be downright dangerous. The late-night lifestyle was shown to dramatically raise diabetes risk and cause several other health-damaging effects.

Weight training can be an intimidating and time-consuming exercise, but studies have shown that even light strength-work can speed up weight loss, stave off muscle loss and improve sleep. Now, one clever system has made it not just simple but enjoyable.

A new study has found a link between the popular drug Ozempic and suicidal thoughts. While the researchers cannot establish causation, they say the link needs to be investigated further so that people can be informed of the potential risks.

Diet has a huge role in health and disease as we age, but making long-term changes are not easy. Now, researchers believe it only takes two months of eating differently to significantly reduce your 'biological' age across five major organ systems.

A compound that occurs in mature olives and olive oil can regulate glucose and ramp up weight loss in rapid time, mimicking the effects of existing medication. This opens the door for developing safe, natural treatments for obesity and type 2 diabetes.

The popular class of antidiabetic and weight loss drugs known as GLP-1RAs, which includes Ozempic and Wegovy, has been found to significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetics, according to new research.

Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of developing a relatively rare form of untreatable blindness, sometimes referred to as an 'eye stroke,' a new study has found.

By suppressing one protein, stores of white fat can switch to calorie-burning beige fat, in a feat that so far has eluded scientists working in this field. This means long-lasting weight loss without the brain-gut side effects of existing obesity drugs.